{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:52:03Z","timestamp":1793159523811,"version":"4.5.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ECCOJC"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1093\/ecco-jcc\/jjv234","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T02:42:55Z","timestamp":1452566575000},"page":"979-988","source":"Crossref","is-referenced-by-count":64,"title":["Anti-Tumour Necrosis Factor \u03b1 Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis"],"prefix":"10.1093","volume":"10","author":[{"given":"Zaid","family":"Shihab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville D.","family":"Yeomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"2016072703580791000_10.8.979.1","first-page":"287","article-title":"Crohn\u2019s disease\u2014occurrence, course and prognosis. An epidemiologic cohort-study","volume":"44","author":"Munkholm","year":"1997","journal-title":"Dan Med Bull"},{"key":"2016072703580791000_10.8.979.2","doi-asserted-by":"crossref","first-page":"S-265","DOI":"10.1016\/S0016-5085(15)30875-1","article-title":"The influence of disease activity on birth outcome in patients with inflammatory bowel disease: meta-analysis","volume":"148","author":"Park","year":"2015","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00054725-199603000-00006","article-title":"Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women","volume":"2","author":"Connell","year":"1996","journal-title":"Inflamm Bowel Dis"},{"key":"2016072703580791000_10.8.979.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01852.x"},{"key":"2016072703580791000_10.8.979.5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.464"},{"key":"2016072703580791000_10.8.979.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3677-x"},{"key":"2016072703580791000_10.8.979.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.04.009"},{"key":"2016072703580791000_10.8.979.8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Birth Defects in Victoria 2005\u20132006","volume":"60","author":"Mowat","year":"2008","journal-title":"Gut"},{"key":"2016072703580791000_10.8.979.9","first-page":"233","article-title":"Anti-TNF therapy in inflammatory bowel diseases: a huge review","volume":"56","author":"Peyrin-Biroulet","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2016072703580791000_10.8.979.10","doi-asserted-by":"publisher","DOI":"10.3109\/00365520903362628"},{"key":"2016072703580791000_10.8.979.11","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20839"},{"key":"2016072703580791000_10.8.979.12","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20082"},{"key":"2016072703580791000_10.8.979.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.140822"},{"key":"2016072703580791000_10.8.979.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2016072703580791000_10.8.979.15","unstructured":"Wells GA Shea B O\u2019Connell D . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2014. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed December 7, 2015."},{"key":"2016072703580791000_10.8.979.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"2016072703580791000_10.8.979.17","unstructured":"Bax L . Professional software for meta-analysis in Excel. Version 2.0.1.4. BiostatXL, 2011. http:\/\/www.meta-analysis-made-easy.com. Accessed December 12, 2015."},{"key":"2016072703580791000_10.8.979.18","unstructured":"Victorian Perinatal Data Collection Unit. Birth Defects in Victoria, 2006. http:\/\/www.health.vic.gov.au\/__data\/assets\/pdf_file\/0006\/313872\/bd_05-06.pdf. Accessed September 17, 2015."},{"key":"2016072703580791000_10.8.979.19","unstructured":"NSW Ministry of Health. NSW Mothers and Babies 2009, 2011. http:\/\/www.health.nsw.gov.au\/phb\/Publications\/NSW-mothers-babies-2009.pdf. Accessed December 7, 2015."},{"key":"2016072703580791000_10.8.979.20","unstructured":"Spanish National Registry. Annual Report of Epidemiological Surveillance of Congenital Anomalies in Spain: Data of the Period 1980\u20132010, 2010. http:\/\/revista.isciii.es\/index.php\/ecemc\/article\/viewFile\/724\/781. Accessed December 7, 2015."},{"key":"2016072703580791000_10.8.979.21","unstructured":"European Surveillance of Congenital Anomalies (EUROCAT). Prevalence Data, 2012. http:\/\/www.eurocat-network.eu\/AccessPrevalenceData\/PrevalenceTables. Accessed December 7, 2015."},{"key":"2016072703580791000_10.8.979.22","unstructured":"New York State Department of Health. Statistical Summary of Children Born in 1983\u20132007. https:\/\/www.health.ny.gov\/diseases\/congenital_malformations\/2013\/docs\/cmr_25.pdf. Accessed December 7, 2015."},{"key":"2016072703580791000_10.8.979.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60563-8"},{"key":"2016072703580791000_10.8.979.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60456-6"},{"key":"2016072703580791000_10.8.979.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.04.011"},{"key":"2016072703580791000_10.8.979.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(13)60626-1"},{"key":"2016072703580791000_10.8.979.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.011"},{"key":"2016072703580791000_10.8.979.28","doi-asserted-by":"publisher","DOI":"10.4321\/S1130-01082012000200003"},{"key":"2016072703580791000_10.8.979.29","doi-asserted-by":"crossref","first-page":"S621","DOI":"10.14309\/00000434-201210001-01543","article-title":"Outcomes of pregnancy in subjects exposed to certolizumab pegol","volume":"107","author":"Mahadevan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2016072703580791000_10.8.979.30","first-page":"S-385","article-title":"Prospective assessment of the adalimumab discontinuation during pregnancy in inflammatory bowel disease patients","volume":"142","author":"Zelinkova","year":"2012","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.31","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21368"},{"key":"2016072703580791000_10.8.979.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.02.004"},{"key":"2016072703580791000_10.8.979.33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2011.04.030","article-title":"Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab","volume":"65","author":"Heller","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2016072703580791000_10.8.979.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02405.x"},{"key":"2016072703580791000_10.8.979.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30186.x"},{"key":"2016072703580791000_10.8.979.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60049-0"},{"key":"2016072703580791000_10.8.979.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(13)60422-5"},{"key":"2016072703580791000_10.8.979.38","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1016\/S0016-5085(13)61521-8","article-title":"Maternal and fetal adverse outcomes with tumor necrosis factor alpha inhibitors in inflammatory bowel disease patients: an analysis of the food and drug administration adverse event reporting system","volume":"144","author":"Deepak","year":"2013","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.39","doi-asserted-by":"crossref","unstructured":"de Lima A Zelinkova Z van der Ent C Steegers E van der Woude C Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. Gut 2015 May 12. pii: gutjnl-2015\u2013309321. doi: 10.1136\/gutjnl-2015-309321.","DOI":"10.1136\/gutjnl-2015-309321"},{"key":"2016072703580791000_10.8.979.40","doi-asserted-by":"crossref","first-page":"S-454","DOI":"10.1016\/S0016-5085(15)31532-8","article-title":"Serum TNF- \u03b1 level changes during pregnancy are associated with timing of delivery in IBD patients","volume":"148","author":"Leung","year":"2015","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.41","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.463"},{"key":"2016072703580791000_10.8.979.42","doi-asserted-by":"crossref","first-page":"S-261","DOI":"10.1016\/S0016-5085(15)30860-X","article-title":"Stopping infliximab during pregnancy in inflammatory bowel disease","volume":"148","author":"Truta","year":"2015","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.43","first-page":"104","article-title":"Anti-TNF therapy use in pregnant patients with Crohn\u2019s disease and ulcerative colitis","volume":"29","author":"Kiely","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2016072703580791000_10.8.979.44","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/00365521.2013.812141","article-title":"Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study","volume":"48","author":"Bortlik","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"2016072703580791000_10.8.979.45","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140189"},{"key":"2016072703580791000_10.8.979.46","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12833"},{"key":"2016072703580791000_10.8.979.47","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.56"},{"key":"2016072703580791000_10.8.979.48","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.430"},{"key":"2016072703580791000_10.8.979.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.024"},{"key":"2016072703580791000_10.8.979.50","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21583"},{"key":"2016072703580791000_10.8.979.51","first-page":"S730","article-title":"Pregnancy outcomes in women exposed to adalimumab: an update on the autoimmune diseases in pregnancy project","volume":"63","author":"Johnson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2016072703580791000_10.8.979.52","first-page":"264","article-title":"Successfully multiple pregnancies in Crohn\u2019s disease under long-term treatment with adalimumab","volume":"76","author":"Tursi","year":"2013","journal-title":"Acta Gastroenterol Belg"},{"key":"2016072703580791000_10.8.979.53","first-page":"243","article-title":"A case report: feasible treatment of adalimumab for Crohn disease during pregnancy. [Japanese.]","volume":"110","author":"Tsujikawa","year":"2013","journal-title":"J Gastroenterol"},{"key":"2016072703580791000_10.8.979.54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2169\/internalmedicine.52.9466","article-title":"Maintenance of the remission stage of Crohn\u2019s disease with adalimumab therapy during pregnancy","volume":"52","author":"Mizoshita","year":"2012","journal-title":"Intern Med"},{"key":"2016072703580791000_10.8.979.55","first-page":"75","article-title":"Biological treatment of patient with ulcerative colitis during pregnancy","volume":"65","author":"Kozeluhova","year":"2011","journal-title":"Cesk Sloven Gastroent Hepatol"},{"key":"2016072703580791000_10.8.979.56","first-page":"S131","article-title":"Inflammatory bowel disease in pregnancy: report of a case treated with infliximab and literature review","volume":"180","author":"Abdul Wahab","year":"2011","journal-title":"Ir J Med Sci"},{"key":"2016072703580791000_10.8.979.57","first-page":"S132","article-title":"Humira in pregnancy for Crohn\u2019s disease: a case report","volume":"180","author":"Abdul Wahab","year":"2011","journal-title":"Ir J Med Sci"},{"key":"2016072703580791000_10.8.979.58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04617.x"},{"key":"2016072703580791000_10.8.979.59","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21226"},{"key":"2016072703580791000_10.8.979.60","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-010-0158-9"},{"key":"2016072703580791000_10.8.979.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.05.001"},{"key":"2016072703580791000_10.8.979.62","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328329543a"},{"key":"2016072703580791000_10.8.979.63","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21198"},{"key":"2016072703580791000_10.8.979.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.08.006"},{"key":"2016072703580791000_10.8.979.65","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20319"},{"key":"2016072703580791000_10.8.979.66","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3085"},{"key":"2016072703580791000_10.8.979.67","first-page":"A144","article-title":"Infliximab levels in infants born to women with inflammatory bowel disease","volume":"132","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.01.017"},{"key":"2016072703580791000_10.8.979.69","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9452-2"},{"key":"2016072703580791000_10.8.979.70","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200608000-00020"},{"key":"2016072703580791000_10.8.979.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.07.018"},{"key":"2016072703580791000_10.8.979.72","first-page":"138","article-title":"Pregnancy and Crohn\u2019s disease: infliximab induction therapy, accidental conception, pregnancy outcome and postpartum complications","volume":"19","author":"Xirouchakis","year":"2006","journal-title":"Ann Gastroenterol"},{"key":"2016072703580791000_10.8.979.73","doi-asserted-by":"publisher","DOI":"10.1157\/13077767"},{"key":"2016072703580791000_10.8.979.74","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02983.x"},{"key":"2016072703580791000_10.8.979.75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03987.x"},{"key":"2016072703580791000_10.8.979.76","first-page":"111","article-title":"Experience of biologic therapy during pregnancy for inflammatory bowel disease in a tertiary centre in Western Australia","volume":"27","author":"Muwanwella","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"2016072703580791000_10.8.979.77","first-page":"262","article-title":"Biologic therapy in pregnant women with inflammatory bowel disease","volume":"27","author":"Martinez","year":"2014","journal-title":"J Matern Fetal Neonat Med"},{"key":"2016072703580791000_10.8.979.78","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000221"},{"key":"2016072703580791000_10.8.979.79","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.218"},{"key":"2016072703580791000_10.8.979.80","doi-asserted-by":"crossref","first-page":"S-149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.81","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31817f9367"},{"key":"2016072703580791000_10.8.979.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.002"},{"key":"2016072703580791000_10.8.979.83","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.6318"},{"key":"2016072703580791000_10.8.979.84","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.625"},{"key":"2016072703580791000_10.8.979.85","doi-asserted-by":"crossref","first-page":"S-378","DOI":"10.1016\/S0016-5085(15)31268-3","article-title":"Long-term outcome of children born to IBD mothers: preliminary result from a multicenter retrospective study in the Netherlands","volume":"148","author":"Kanis","year":"2015","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.86","doi-asserted-by":"crossref","unstructured":"Mahadevan U Vermeire S Wolf DC Pregnancy outcomes after exposure to certolizumab pegol: updated results from safety surveillance. Gastroenterology;148:S-858\u2013S-859.","DOI":"10.1016\/S0016-5085(15)32908-5"},{"key":"2016072703580791000_10.8.979.87","doi-asserted-by":"crossref","first-page":"S-170","DOI":"10.1016\/S0016-5085(14)60602-8","article-title":"Exposure to anti-TNF\u03b1 therapy in the third trimester of pregnancy is not associated with increased adverse outcomes: results from the PIANO registry","volume":"146","author":"Mahadevan","year":"2014","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.88","first-page":"S-385","article-title":"Early discontinuation of infliximab during pregnancy reduces neonatal exposure to infliximab and is safe for the inflammatory bowel disease patients","volume":"142","author":"Zelinkova","year":"2012","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.89","doi-asserted-by":"crossref","first-page":"A-27","DOI":"10.1016\/S0016-5085(09)60125-6","article-title":"Pregnancy outcomes in women exposed to adalinumab: the OTIS Autoimmune Diseases in Pregnancy Project","volume":"136","author":"Johnson","year":"2009","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.90","first-page":"S251","article-title":"Pregnancy outcome in women exposed to adalimumab: the OTIS Autoimmune Diseases in Pregnancy Project","volume":"54","author":"Chambers","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2016072703580791000_10.8.979.91","doi-asserted-by":"crossref","first-page":"S-175","DOI":"10.1016\/S0016-5085(11)60708-7","article-title":"Anti-TNF therapy and pregnancy in inflammatory bowel disease: a prospective cohort study from the GETAID","volume":"140","author":"Seirafi","year":"2011","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2013.11.004"},{"key":"2016072703580791000_10.8.979.93","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000092"},{"key":"2016072703580791000_10.8.979.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.011"},{"key":"2016072703580791000_10.8.979.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.024"},{"key":"2016072703580791000_10.8.979.96","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrgastro.2012.248","article-title":"IBD: can TNF inhibitors be administered during the third trimester?","volume":"10","author":"Nielsen","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2016072703580791000_10.8.979.97","first-page":"95","article-title":"Intra-uterine exposure to anti-TNF-\u03b1 therapy (ERA study): neonatal levels of anti TNF antibodies correlate with duration of therapy in pregnancy","volume":"28","author":"Julsgaard","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2016072703580791000_10.8.979.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2007.00499.x"},{"key":"2016072703580791000_10.8.979.99","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000440984.86659.4f"},{"key":"2016072703580791000_10.8.979.100","doi-asserted-by":"crossref","first-page":"S-378","DOI":"10.1016\/S0016-5085(15)31268-3","article-title":"Long-term outcome of children born to IBD mothers: preliminary result from a multicenter retrospective study in the Netherlands","volume":"148","author":"Kanis","year":"2015","journal-title":"Gastroenterology"},{"key":"2016072703580791000_10.8.979.101","unstructured":"Borenstein M Hedges LV Higgins JP Rothstein HR. Introduction to Meta-analysis . Chichester, UK: John Wiley & Sons, 2011."}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/10\/8\/979\/7093560\/jjv234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:31:38Z","timestamp":1600032698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1093\/ecco-jcc\/jjv234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":101,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,7,27]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1093\/ecco-jcc\/jjv234"],"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv234","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}